Related Experiment Video
Updated: Aug 12, 2026
09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Variables that influence response to different interferon schedules in chronic hepatitis C and predictive models
G L De Salvo1, F Noventa, L Chemello
1Department of Clinical and Experimental Medicine, University of Padova, Italy.
Journal of Viral Hepatitis
|January 1, 1997
Summary
Higher doses of interferon-alpha therapy improve sustained response rates in chronic hepatitis C (HCV) patients. Incorporating hepatitis C virus (HCV) genotype significantly enhances treatment prediction models.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Chronic hepatitis C (HCV) treatment with standard interferon therapy yields limited sustained response rates (10-20%).
- Some patients require higher interferon dosages or longer treatment durations for sustained response.
- Predictive factors for sustained response in chronic hepatitis C are not fully elucidated.
Purpose of the Study:
- To analyze sustained response rates in chronic hepatitis C patients treated with interferon-alpha across different subgroups and schedules.
- To evaluate the cost-effectiveness of higher dose interferon regimens, particularly in patients with cirrhosis.
- To develop and compare predictive models for sustained response, assessing the impact of hepatitis C virus (HCV) genotype.
Main Methods:
- Analysis of a large database of 442 patients with chronic hepatitis C treated with interferon-alpha.
- Stratification of patients based on age, pre-treatment liver histology, and HCV genotype.
- Development and comparison of predictive models for sustained response, including HCV genotype as a variable.
Main Results:
- Higher dose interferon-alpha regimens increased sustained response rates across most patient categories (age, histology, genotype).
- The amount of interferon required per sustained response remained stable or decreased with higher doses.
- Higher dose regimens were particularly cost-effective in patients with cirrhosis.
- Inclusion of HCV genotype significantly improved the specificity and sensitivity of predictive models for sustained response.
Conclusions:
- Optimizing interferon-alpha dosage based on patient subgroups can enhance sustained response rates in chronic hepatitis C.
- HCV genotype is a crucial factor influencing sustained response and should be integrated into predictive models.
- Higher dose interferon therapy can be a cost-effective strategy, especially for patients with cirrhosis.
More Related Videos
10:00High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Related Concept Videos
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:16Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...